SEC Form 4 · accession 0001209191-17-060480

KYNTRA BIO, INC. · KYNB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — VP, Finance and CFO

Period of report

Nov 9, 2017

Accepted (ET)

Nov 13, 2017 · 8:14 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000921299

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Nov 9, 2017	M	32,407	$2.90	A	189,812	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F1	$2.90	Nov 9, 2017	M	4,357	D	—	Jun 24, 2020	Common Stock	4,357	0	D
Stock Option (Right to Buy)^F1	$2.90	Nov 9, 2017	M	4,000	D	—	Jun 24, 2020	Common Stock	4,000	0	D
Stock Option (Right to Buy)^F1	$2.90	Nov 9, 2017	M	17,600	D	—	Jun 24, 2020	Common Stock	17,600	0	D
Stock Option (Right to Buy)^F1	$2.90	Nov 9, 2017	M	6,450	D	—	Jun 24, 2020	Common Stock	6,450	1,550	D